APO 131 (Carbidopa and Levodopa Extended Release 25 mg / 100 mg)
Pill with imprint APO 131 is Red, Round and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Apotex Corp.
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO 131
Carbidopa and Levodopa Extended Release
- Imprint
- APO 131
- Strength
- 25 mg / 100 mg
- Color
- Red
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-0131 (Discontinued)
- Inactive Ingredients
-
hypromelloses,
magnesium stearate,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "APO 131"
More about carbidopa / levodopa
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (85)
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
- Other brands
- Sinemet, Rytary, Sinemet CR, Duopa, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.